Detection and quantification of TEL/AML1 fusion transcripts by polymerase chain reaction in childhood acute lymphoblastic leukemia

Leukemia

Volumn 10, Issue 9, 1996, Pages 1463-1470

  Nakao, M ^a   Yokota, S ^a   Horiike, S ^a   Taniwaki, M ^a   Kashima, K ^a   Sonoda, Y ^a   Koizumi, S ^b   Takaue, Y ^c   Matsushita, T ^d   Fujimoto, T ^e   Misawa, S ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Minimal residual disease; RT PCR; t(12; 21); Translocation

Indexed keywords

MESSENGER RNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW; CHILD; CHILDHOOD LEUKEMIA; EXON; EXPRESSION VECTOR; FEMALE; GENE FUSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 9544235164     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hayashi Y, Raimondi SC, Look AT, Behm FG, Kitchingman GR, Pui CH, Rivera GK, Williams DL. Abnormalities of the long arm of chromosome 6 in childhood acute lymphoblastic leukemia. Blood 1990; 76: 1626-1630.
2. Menasce LP, Orphanos V, Santibanez-Koref M, Boyl JM, Harrison CJ. Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukemia. Genes Chromos Cancer 1994; 10: 286-288.
3. Chilcote RR, Brown E, Rowley JD. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. New Engl J Med 1985; 313: 286-291.
4. Smith SD, Link MP, Trela M, Amylon M, Sklar J, Morgan R, Hecht F. Chromosome 9 abnormalities in childhood T-cell leukemia. New Engl J Med 1986; 313: 195-196.
5. Murphy SB, Raimondi SC, Rivera GK, Crone M, Dodge RK, Behm FC, Pui C-H, Williams DL. Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood 1989; 74: 409-415.
6. Raimondi SC, Williams DL, Callihan T, Peiper S, Rivera GK, Murphy SB. Nonrandom involvement of the 12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 1986; 68: 69-75.
7. Raimondi SC, Rivera GK, Pui C-H, Mahmoud H, Look AT, Williams DL. Frequency and heterogeneity of 12p structural abnormalities, including a new pericentric inversion, in childhood acute lymphoblastic leukemia. Cytogenet Cell Genet 1991; 58: 27301a (Abstr.).
8. Mahmoud H, Carroll AJ, Behm F, Raimondi SC, Schuster J, Borowitz M, Land V, Pullen DJ, Vietti TJ, Crist W. The non-random dic(9;12) translocation in acute lymphoblastic leukemia is associated with 8-progenitor phenotype and an excellent prognosis. Leukemia 1992; 6: 703-707.
9. Romana SP, Le Coniat M, Berger R. t(12;21):a new recurrent translocation in acute lymphoblastic leukemia. Genes Chromos Cancer 1994; 9: 186-191.
10. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM, Le Beau MM, Roberts JM, Vogelstein B, Rowley JD, Bohtander SK. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 1995; 86: 1525-1533.
11. Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res 1995; 55: 1206-1210.
12. kip1: chromosomal mapping to 12p12-12p13,1 and absence of mutations in human tumors. Cancer Res 1995; 55: 1211-1214.
13. Morosetti R, Kawamata N, Gombart AF, Miller CW, Hatta Y, Hirama T, Said JW, Tomonaga M, Koeffler HP. Alterations of the p27KIP1 gene in non-Hodgkin's lymphoma and adult T-cell leukemia/lymphoma. Blood 1995; 86: 1924-1930.
14. Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S, Lee YY, Bartram CR, Koeffler HP. Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res 1995; 55: 2266-2269.
15. Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M, Bohlander SK, Rowley JD, Sallan SE, Gilliland DG, Golub TR. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 1995; 86: 38-44.
16. Kip1. Blood 1995; 86: 3869-3875.
17. Golub TR, Barker GF, Lovett M, Gilliland DG. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 1994; 77: 307-316.
18. Wlodarska I, Mecucci C, Marynen P, Guo C, Franckx D, La Starza R, Aventin A, Bosly A, Martelli MF, Cassiman JJ, Van den Berghe H. TEL gene is involved in myelodysplastic syndromes with either the typical t(5;12)(q33;p13) translocation or its variant t(10;12)(q24;p13). Blood 1995; 85: 2848-2852.
19. Buijs A, Sherr S, van Baal S, van Bezouw S, van der Plas D, van Kessel AG, Riegman P, Deprez RL, Zwarthoff E, Hagemeijer A, Grosveld G. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11. Oncogene 1995; 10: 1511-1519.
20. Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM. The novel activation of ABL by fusion to an els-related gene, TEL. Cancer Res 1995; 55: 34-38.
21. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991; 88: 10431-10434.
22. Gao J, Erickson P, Gardiner K, Le Beau MM, Diaz MO, Patterson D, Rowley JD, Drabkin HA. Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia. Proc Natl Acad Sci USA 1991; 88: 4882-4886.
23. Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley JD, Drabkin H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825-1831.
24. Nucifora G, Birn D, Erickson P, Gao I, Le Beau MM, Drabkin HA, Rowley JD. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993; 81: 883-888.
25. Miyoshi H, Ohi'ra M, Shimizu K, Mitani K, Hirai H, Imai T, Yokoyama K, Soeda E, Ohki M. Alternative splicing and genomic structure of the AMLI gene involved in acute myeloid leukemia. Nucleic Acids Res 1995; 23: 2762-2769.
26. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, Yazaki Y, Ohki M, Hirai H. Generation of the AML1-EVI-1 fusion gene in the t(3;21 Kq26;q22) causes blastic crisis in chronic myelocytic eukemia. EMBO J 1994; 13: 504-510.
27. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, BrayWard P, Morgan E, Raimondi SC, Rowley JD. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995; 92: 4917-4921.
28. Romana SP, Mauchauffé M, Le Coniat M, Chumakov I, Le Paslier D, Berger R, Bernard OA. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 1995; 85: 3662-3670.
29. Romana SP, Poirel H, Le Coniat M, Flexor M-A, Mauchauffé M, Jonveaux P, Macintyre EA, Berger R, Bernard OA. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 1995; 86: 4263-4269.
30. Golub T, McLean T, Stegmaier K, Ritz J, Sallan S, Neuberg D, Gilliland DG. TEL-AML1: the most common gene rearrangement in childhood ALL. Blood 1995; 86: (Suppl) 597a.
31. Shurtleff SA, Buijs A, Behm FG, Rubnitz JE, Raimondi SC, Hancock ML, Chan CC-F, Pui C-H, Grosveld G, Downing JR. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 1995; 9: 1985-1989.
32. Raynaud SD, Cavé H, Baens M, Bastard C, Cacheux V, Grosgeorge J, Vilmer E, Marynen P, Grandchamp B. The t(12;21) translocation and deletions of chromosome 12p12-13: a two hits alteration of TEL frequently involved in children with acute lymphoblastic leukemias. Blood 1995; 86: (Suppl) 598a.
33. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. The morphological classification of acute lymphoblastic leukaemia; concordance among observers and clinical correlations. Br J Haematol 1981; 47: 553-561.
34. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
35. Yamada M, Hudson S, Tournay O, Bittenbender S, Shane SS, Lange B, Tsujimoto Y, Canton AJ, Rovera G. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc Natl Acad Sci USA 1989; 86: 5123-5127.
36. Yokota S, Hansen-Hagge TE, Ludwig WD, Reiter A, Raghavachar A, Kleihauser E, Bartram CR. Use of polymerase chain reaction to monitor minimal residual disease in acute lymphoblastic leukemia patients. Blood 1991; 77: 331-339.
37. Chang K-S, Fan Y-H, Stass SA, Estey EH, Wang G, Trujillo JM, Erickson P, Drabkin H. Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia. Oncogene 1993; 8: 983-988.
38. Devaraj PE, Foroni L, Janossy G, Hoffbrand AV, Seeker-Walker LM. Expression of the E2A-PBX1 fusion transcripts in t(1;19)(q23;p13) and der(19)t(1;19) at diagnosis and in remission of acute lymphoblastic leukemia with different B lineage immunophenotypes. Leukemia 1995; 9: 821-825.
39. Takatsuki H, Umemura T, Sadamura S, Yamashita S, Goto T, Abe Y, Yufu Y, Inaba S, Nishimura J, Nawata H. Detection of minimal residual disease by reverse transcriptase polymerase chain reaction for the PML/RARa fusion mRNA: a study in patients with acute promyelocytic leukemia following peripheral stem cell transplantation. Leukemia 1995; 9: 889-892.
40. van Rhee F, Marks DI, Lin F, Szydlo RM, Hochhaus A, Treleaven J, Delord C, Cross NCP, Goldman JM. Quantification of residual disease in Philadelphia-positive acute lymphoblastic leukemia: comparison of blood and bone marrow. Leukemia 1995; 9: 329-335.
41. Lion T, Gaiger A, Henn T, Hörth E, Haas OA, Geissler K, Gadner H. Use of quantitative polymerase chain reaction to monitor residual disease in chronic myelogenous leukemia during treatment with interferon. Leukemia 1995; 9: 1353-1360.
42. Seriu T, Yokota S, Nakao M, Misawa S, Takaue Y, Koizumi S, Kawai S, Fujimoto T. Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation. Leukemia 1995; 9: 615-623.
43. Steenbergen EJ, Verhagen OJHM, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne AEGKr, van der Schoot CE. Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia. Leukemia 1995; 9: 1726-1734.
44. Chim JCS, Coyle LA, Yaxley JC, Cole-Sinclair MF, Cannell PK, Hoffbrand VA, Foroni L. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. Br J Haematol 1996; 92: 104-115.
45. Baruchel A, Cayuela JM, Macintyre E, Berger R, Sigaux F. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PRC derived methods: implication for a general strategy of minimal residual disease detection. Br J Haematol 1995; 90: 85-93.
46. Steward CG, Couldon NJ, Katz F, Martin PG, Langlands K, Potter MN, Chessel JM, Oakhill AA. A polymerase chain reaction study of the stability of IgH heavy-chain and T-cell receptor δ gene rearrangements between presentation and relapse of childhood Blineage acute lymphoblastic leukemia. Blood 1994; 83: 1355-1362.
47. Steenbergen EJ, Verhagen OJHM, van Leeuwen EF, van den Berg H, von dem Borne AEGKr, van der Schoot CE. Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease. Blood 1995; 86: 692-702.
48. Ghali DW, Panzer S, Fischer S, Argyriou-Tirita A, Haas OA, Kovar H, Gadner H, Panzer-Grümayer ER. Heterogeneity of the T-cell receptor δ gene indicating subclone formation in acute precursor B-cell leukemia. Blood 1995; 85: 2795-2801.
49. Menssen HD, Renkl H-J, Rodeck U, Maurer J, Notter M, Schwartz S, Reinhardt R, Thiel E. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995; 9: 1060-1067.